Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 53.8 EUR 0.19% Market Closed
Market Cap: 516.9m EUR
Have any thoughts about
Pharmanutra SpA?
Write Note

Pharmanutra SpA
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharmanutra SpA
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Pharmanutra SpA
MIL:PHN
Intangible Assets
€5.7m
CAGR 3-Years
31%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Intercos SpA
MIL:ICOS
Intangible Assets
€56.2m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Bioera SpA
MIL:BIE
Intangible Assets
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Enervit SpA
MIL:ENV
Intangible Assets
€4.2m
CAGR 3-Years
31%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Pharmanutra SpA
Glance View

Market Cap
516.9m EUR
Industry
Consumer products

Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

PHN Intrinsic Value
43.41 EUR
Overvaluation 19%
Intrinsic Value
Price

See Also

What is Pharmanutra SpA's Intangible Assets?
Intangible Assets
5.7m EUR

Based on the financial report for Jun 30, 2024, Pharmanutra SpA's Intangible Assets amounts to 5.7m EUR.

What is Pharmanutra SpA's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
22%

Over the last year, the Intangible Assets growth was 22%. The average annual Intangible Assets growth rates for Pharmanutra SpA have been 31% over the past three years , 22% over the past five years .

Back to Top